Kunihiro Yoshioka
Papers
1
Total Citations
21
H-Index
1
About
Dr. Kunihiro Yoshioka is a prominent urologic oncologist whose research centers on prostate cancer risk stratification and treatment optimization. His most cited work, a 2015 study on preoperative predictive factors for biochemical recurrence in high-risk prostate cancer, has garnered 21 citations and provides critical tools for personalizing therapy. Dr. Yoshioka’s major contribution lies in refining risk assessment models, enabling clinicians to better identify patients who may benefit from more aggressive intervention. By analyzing clinical and pathological variables, his research helps reduce overtreatment while improving outcomes for those with aggressive disease. His work has been instrumental in advancing the understanding of biochemical recurrence—a key endpoint in prostate cancer management—and has influenced surgical and adjuvant therapy decisions. Dr. Yoshioka’s dedication to evidence-based, patient-centered care is evident in his focus on translating complex data into practical clinical guidance. For students and researchers, his studies underscore the importance of integrating predictive analytics into oncology, offering a blueprint for how targeted risk stratification can enhance precision medicine in urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1